Table 4.
Effects of SNPs and vitamins on Hcy levels in patients with epilepsy receiving OXC monotherapy.
| Model | Unstandardized coefficients | Standardized coefficients | P-value | VIF | R2 | |
|---|---|---|---|---|---|---|
| β | Std. error | Beta | ||||
| (Constant) | 21.058 | 2.895 | <0.001 | 0.378 | ||
| rs1801133 CT | −1.534 | 1.746 | −0.092 | 0.383 | 1.141 | |
| rs1801133 TT | 13.282 | 3.729 | 0.370 | 0.001 | 1.124 | |
| rs1801198 CC | 5.432 | 2.297 | 0.246 | 0.021 | 1.127 | |
| rs1801198 GG | −0.473 | 1.838 | −0.027 | 0.798 | 1.125 | |
| FA (nmol/l) | −0.334 | 0.106 | −0.327 | 0.002 | 1.119 |
The overall significance for Hcy levels was F = 7.891; P < 0.001. P < 0.05 was considered a statistically significant difference.
FA, folate; VIF, variable inflation factor.